Research
The desire for furtherance of knowledge and continued development of products drives WellSpring to strive for constant improvement.
WellSpring is currently conducting a survey regarding consumer use of Glaxal Base® Cream in radiation clinics throughout the United States. WellSpring holds the belief that a simple solution makes a difference in the lives of others, such as the use of a quality moisturizer to soothe the skin while undergoing radiation treatment. Please contact the Regulatory department at: regulatory@wellspringpharm.com
“New drug development can be a lengthy process requiring years of research and millions of dollars in costs. WellSpring develops new prescription drugs and over the counter consumer pharmaceuticals. Our research programs and development processes meet or exceed Federal standards regardless of prescription or OTC status”
-Dr. V